Effects of Omega 3 in Hemodialysis Patients

Laboratoire Régional de Nutrition Humaine8 enrolled

Overview

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

Hemodialysis End Stage Renal Disease

Interventions

fish oil supplementationBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * hemodialysis at least 6 months duration end stage renal disease Exclusion Criteria: * \- Age \< 18 y ou \> 75 y * Hemodialysis \< 6 months * Diabetes, obesity * allergy to fish * Asthma * glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin * erythropoïetin \< 3 months * Cancer * Hemoglobin \< 11 g/l * disease \< 1 month * pregnancy * respiratory insufficiency * intensive sport practice * refusal

Locations (1)

Laboratoire Régional de Nutrition Humaine

Brest, France

Outcomes

Primary Outcomes

plasma glucose utilization

glucose-induced thermogenesis

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.